Harpagophytum procumbens clinical trials
How each study uses Harpagophytum procumbens is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Harpagophytum Procumbens
- 2
Studies by the year they started
3 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2014 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Jaseng Hospital of Korean Medicine (1) · University of Southampton (1) · University of Missouri-Columbia (1)
Often tested with
Tested in the same studies.
Harpagophytum extract LI 174 (1)
Studies
Open first, then newest update. How each study uses Harpagophytum procumbens is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Bioavailability and Pharmacokinetic Measures of H. Procumbens ExtractWithdrawnEarly Phase 1University of Missouri-ColumbiaNCT03641248Written as Enteric coated Devil's ClawHow we know
- Immediate Pain Relieving Effects of Sinbaro-3 for Low Back PainCompletedPhase 3Jaseng Hospital of Korean MedicineNCT02196129Written as Sinbaro-3How we know
- Trial Evaluating Devil's Claw for the Treatment of Hip and Knee OsteoarthritisTerminatedPhase 2University of SouthamptonNCT00295490Written as Devil ClawHow we know
Codes
What other systems call Harpagophytum procumbens · ClinicalTrials.gg INT016146
- RxNorm 236279One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 236279 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.